Showing results (431-440 of 541) with videos related to
Sort By:
Pageof 55
Journal of Experimental & Clinical Cancer Research : CR|May 16, 2025
HBV-driven host chromatin accessibility changes affect liver metabolic pathways, iron homeostasis and promote a preneoplastic phenotypeVincenzo Alfano, Giuseppe Rubens Pascucci, Giacomo Corleone, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV ReplicationGérard-Menan Kouamé, Anders Boyd, Raoul Moh, et al.Gut|December 18, 2014
Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivityCharlène Brault, Pierre Lévy, Sarah Duponchel, et al.Emerging Microbes & Infections|March 15, 2019
Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practiceYan Liu, Yi Zhou, Xiaodong Li, et al.Cell Death & Disease|November 30, 2023
RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin-ferroptosis axisZhili Li, Claude Caron de Fromentel, Woojun Kim, et al.Gastroenterology|June 10, 2004
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyBettina Werle-Lapostolle, Scott Bowden, Stephen Locarnini, et al.Gastroenterology|April 29, 2020
JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic InfectionFabien Zoulim, Oliver Lenz, Joris J Vandenbossche, et al.Plos Biology|April 1, 2016
Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C VirusMarie-Laure Plissonnier, Thomas Lahlali, Maud Michelet, et al.Gut|June 17, 2026
Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortiaHabiba Kamal, Elisabetta Degasperi, Monica Radu, et al.Journal of Viral Hepatitis|May 22, 2020
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohortVictor de Lédinghen, Clovis Lusivika-Nzinga, Jean-Pierre Bronowicki, et al.Pageof 55